Continuum Protocols / Investor overview / September 2026

Continuous care, built to operate.

AI-native products and human-led services for the work between appointments. Starting with KiloCare for Weight and adjacent metabolic care in India.

Public overview. The detailed deck requires email verification when access is enabled.

01 / The opportunity

Care continues between appointments. The operating model should too.

A treatment plan creates weeks of work: follow-up, questions, tests, coordination and review. Continuum is building the products and services to make that work part of a recurring care program.

  • Continuous care: a shared record of the plan, progress and next step.

  • AI-native workflows: organize context, draft follow-up and prepare work for review.

  • Human control: qualified clinicians retain clinical assessment and treatment decisions.

02 / What we are building

The patient experience, provider tools and operations, designed together.

Continuum is the institutional and operations layer. The model brings software and service delivery together, with India-based back-office operations and AI-assisted coordination.

  • Patient follow-up: check-ins, reminders and a way to report changes between visits.

  • Care-team workspaces: longitudinal context, review queues and assigned next steps.

  • Program operations: scheduling, diagnostic coordination, fulfilment tracking and quality review.

This describes the product and operating direction. The cost and quality advantage must be demonstrated through delivery, not assumed.

03 / Starting with KiloCare

One focused program before broader expansion.

KiloCare is the committed patient brand for Weight and adjacent metabolic care. India-regulated clinical care belongs at kilocare.in; Continuum owns the institutional, provider and operations layer.

  • Start with a defined recurring care journey.

  • Measure paid retention, appropriate care and delivery cost together.

  • Expand only after the program earns evidence and passes safety and market-readiness gates.

Clinical availability is market-specific. This overview does not offer clinical services globally.

04 / The investment case

Prove a repeatable patient-month.

The thesis is that operating care and building its software together can create a better learning cycle: improve the service, encode repeatable work and measure the result in the next patient cohort.

  • Recurring care-program revenue, rather than a standalone clinic software subscription.

  • Delivery economics that include clinical time, operations and AI costs.

  • Evidence-led expansion into adjacent protocols, rather than an immediate multi-specialty launch.

The deck explains the operating model, business model and next proof points. Confidential financial and diligence materials are shared separately.

05 / Reading and sharing

An open overview. A deck linked to its readers.

This overview is public. Deck access uses a verified email and a short introduction, with no investor approval step once the service is enabled. Forward the link so the next reader can introduce themselves.

  • We collect your name, optional company, verified email and deck opening times for investor relationship management.

  • Reader records are restricted to authorized Continuum operators and scheduled for deletion after 180 days. They are not a marketing subscription.

  • Email hello@bycontinuum.com to request deletion or ask about your information.

  • We can record authenticated deck openings, not every subsequent screenshot, copied page or forwarded file.

Confidential diligence is separate and requires explicit access approval. Do not include patient information in investor enquiries.

Read the operating thesis.

The deck covers the product, service model, economics to prove and next milestones.